SCHEMBL24147679

SCHEMBL24147679

N#Cc1ccccc1OC/C(=C/F)CN

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.62
AOC2 O75106 4/20 0.62
MAOB P27338 4/20 0.62
DAO P14920 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.51
GAA P10253 1/20 0.51
ALDH1A1 P00352 4/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.47
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
AOC3 Q16853 4/20 0.45
TP53 P04637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
HTR2B P41595 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31467392 0.99 MAOA (0.61) MAOAAOC2MAOBDAOSMN1; SMN2
Hydrochloric Acid SCHEMBL31467273 0.87 AOC2 (0.55) MAOAAOC2MAOBDAOSMN1; SMN2
Hydrochloric Acid SCHEMBL31467391 0.85 AOC2 (0.52) MAOAAOC2MAOBDAOSMN1; SMN2
Hydrochloric Acid SCHEMBL31467363 0.85 AOC2 (0.59) MAOAAOC2MAOBDAOALDH1A1
Hydrochloric Acid SCHEMBL31467375 0.78 AOC2 (0.48) MAOAAOC2MAOBDAOAOC3
SCHEMBL3505391 0.77 AOC2 (0.68) MAOAAOC2MAOBDAOSMN1; SMN2
SCHEMBL24147678 0.76 MAOB (0.51) MAOAAOC2MAOBDAOAOC3
SCHEMBL1282142 0.75 AOC2 (0.64) MAOAAOC2MAOBDAOALDH1A1
SCHEMBL1282141 0.75 AOC2 (0.64) MAOAAOC2MAOBDAOALDH1A1
SCHEMBL25355719 0.74 MAOB (0.69) MAOAAOC2MAOBDAOAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257342-A1 HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS PHARMAXIS LTD. (AU) 2023-08-17 US disclosed
US-20230257342-A1 HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS PHARMAXIS LTD. (AU) 2023-08-17 US disclosed
WO-2021258159-A1 HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS PHARMAXIS LTD. (AU) 2021-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257342-A1 HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS AOC2, AOC3, AOC1 MAOA 6/4885AOC2 1/4885MAOB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.